News

Heffter researcher Matt Johnson and his colleagues at Johns Hopkins University have completed a study showing that psilocybin (aka “magic mushrooms”) is a useful treatment for heavy smokers who want to quit. According to Bloomberg.com writer Michelle Fay Cortez:Just two or three experiences with the hallucinogenic...

A recent article in Scientific American highlights the need to reform federal drug policy. In “Turn On, Tune In, Get Better: Psychedelic Drugs Hold Medical Promise,” writer Roni Jacobson describes how the FDA and DEA created a Catch-22 situation for scientists who study psychedelics. The...

An article on the news site Vox features an in-depth interview with Heffter board member Dr. Charles Grob. “The Case for Medical LSD, Mushrooms, and Ecstasy,” by German Lopez, surveys the history and current status of psychedelic research. Dr. Grob discusses the potential of psychedelic...

An article by Kai Kupferschmidt in Science magazine gives a comprehensive survey of current psychedelic research. “High Hopes” focuses on the work of Heffter board member Stephen Ross and includes quotes from board members Roland Griffiths and Franz Vollenweider.“Albert Hofmann, the Swiss chemist who discovered...

According to The Washington Post, new research at Imperial College London shows that subjects injected with the psychedelic drug psilocybin exhibit brain activity that resembles the dreaming state. The researchers found that psilocybin increases activity in parts of the brain associated with emotion, memory, and...

An article in the New York Times “Fashion and Style” section covers the current popularity of the psychedelic beverage ayahuasca. The article features quotes from Heffter board member Charles Grob.“‘It”s a fascinating compound with a great deal to be learned from its effects,’ said Dr....

A new study uses fMRI technology to distinguish the effects of MDMA (“Ecstasy”) and the classic psychedelic psilocybin on the networks within the brain. Researchers found that psilocybin produces unique changes in consciousness.The effects of psilocybin and MDMA on between-network resting state functional connectivity in...

The Purdue University independent daily student newspaper, The Exponent, has a featured article about Heffter’s President and co-founder Dr. David Nichols.AP photoby Reed Sellers“A former Purdue professor is making major headway in a revolutionary method of treatment for psychiatric disorders by facilitating controlled psychedelic trips.“Adjunct...